Complete Hemodynamic Profiling With Pulmonary Artery Catheters in Cardiogenic Shock Is Associated With Lower In-Hospital Mortality

The purpose of this study was to investigate the association between obtaining hemodynamic data from early pulmonary artery catheter (PAC) placement and outcomes in cardiogenic shock (CS). Although PACs are used to guide CS management decisions, evidence supporting their optimal use in CS is lacking...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:JACC. Heart failure 2020-11, Vol.8 (11), p.903-913
Hauptverfasser: Garan, A. Reshad, Kanwar, Manreet, Thayer, Katherine L., Whitehead, Evan, Zweck, Elric, Hernandez-Montfort, Jaime, Mahr, Claudius, Haywood, Jillian L., Harwani, Neil M., Wencker, Detlef, Sinha, Shashank S., Vorovich, Esther, Abraham, Jacob, O’Neill, William, Burkhoff, Daniel, Kapur, Navin K.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The purpose of this study was to investigate the association between obtaining hemodynamic data from early pulmonary artery catheter (PAC) placement and outcomes in cardiogenic shock (CS). Although PACs are used to guide CS management decisions, evidence supporting their optimal use in CS is lacking. The Cardiogenic Shock Working Group (CSWG) collected retrospective data in CS patients from 8 tertiary care institutions from 2016 to 2019. Patients were divided by Society for Cardiovascular Angiography and Interventions (SCAI) stages and outcomes analyzed by the PAC-use group (no PAC data, incomplete PAC data, complete PAC data) prior to initiating mechanical circulatory support (MCS). Of 1,414 patients with CS analyzed, 1,025 (72.5%) were male, and 494 (34.9%) presented with myocardial infarction; 758 (53.6%) were in SCAI Stage D shock, and 263 (18.6%) were in Stage C shock. Temporary MCS devices were used in 1,190 (84%) of those in advanced CS stages. PAC data were not obtained in 216 patients (18%) prior to MCS, whereas 598 patients (42%) had complete hemodynamic data. Mortality differed significantly between PAC-use groups within the overall cohort (p 
ISSN:2213-1779
2213-1787
DOI:10.1016/j.jchf.2020.08.012